Geneva – IOM´s Tuberculosis (TB) control successes surpass target and benefits communities in origin and destination. The sustained high treatment success rate is largely attributed to early detection, active case finding, directly-observed treatment (DOT) and targeted patient-centered, migration-sensitive care.